YorkBridge Wealth Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
AWA
YorkBridge Wealth Partners's AMGN Position: Q4 2022 in Review
YorkBridge Wealth Partners reduced its Amgen (AMGN) stake by 16% in Q4 2022, selling an estimated $319K and leaving 6,440 shares worth $1.69M. The position accounts for 0.43% of the portfolio, ranked #61.
YorkBridge Wealth Partners first reported a position in AMGN in Q4 2016 and has held it in 25 quarters since. The position peaked at $1.72M in Q3 2022. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.
- YorkBridge Wealth Partners held 6,440 shares of Amgen worth $1.69M as of Q4 2022.
- YorkBridge Wealth Partners sold 1,189 Amgen shares in Q4 2022, an estimated $319K.
- Amgen made up 0.43% of YorkBridge Wealth Partners's portfolio in Q4 2022, its #61 holding.
- YorkBridge Wealth Partners first reported a position in Amgen in Q4 2016 and has held it in 25 quarters since.
- YorkBridge Wealth Partners's Amgen position peaked at $1.72M in Q3 2022.
- 2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.
Based on YorkBridge Wealth Partners's 13F filing for Q4 2022, filed 26 Jan 2023.